DK0773221T3 - Stabile krystallinske tetrahydrofolsyre-salte - Google Patents

Stabile krystallinske tetrahydrofolsyre-salte

Info

Publication number: DK0773221T3
Authority: DK; Denmark
Prior art keywords: tetrahydrofolic acid; acid salts; stable crystalline; crystalline tetrahydrofolic; water
Prior art date: 1995-11-07

Application number

DK96116403T

Other languages

Danish (da)

English (en)

Inventor

Hans Rudolf Mueller

Rudolf Moser

Martin Ulmann

Thomas Ammann

Original Assignee

Eprova Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-07

Filing date

1996-10-14

Publication date

2000-07-10

1996-10-14 Application filed by Eprova Ag filed Critical Eprova Ag

2000-07-10 Application granted granted Critical

2000-07-10 Publication of DK0773221T3 publication Critical patent/DK0773221T3/da

Links

MSTNYGQPCMXVAQ-KIYNQFGBSA-N 5,6,7,8-tetrahydrofolic acid Chemical class N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-KIYNQFGBSA-N 0.000 title 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 abstract 1
MSTNYGQPCMXVAQ-NEPJUHHUSA-N 6R-Tetrahydrofolic acid Chemical compound C([C@@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-NEPJUHHUSA-N 0.000 abstract 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
159000000007 calcium salts Chemical class 0.000 abstract 1
238000002425 crystallisation Methods 0.000 abstract 1
159000000003 magnesium salts Chemical class 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D475/00—Heterocyclic compounds containing pteridine ring systems
- C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
- C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Steroid Compounds (AREA)
Pyridine Compounds (AREA)

DK96116403T 1995-11-07 1996-10-14 Stabile krystallinske tetrahydrofolsyre-salte DK0773221T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH03145/95A CH689831A5 (de)	1995-11-07	1995-11-07	Stabile kristalline Tetrahydrofolsaeure-Salze.

Publications (1)

Publication Number	Publication Date
DK0773221T3 true DK0773221T3 (da)	2000-07-10

Family

ID=4249585

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96116403T DK0773221T3 (da)	1995-11-07	1996-10-14	Stabile krystallinske tetrahydrofolsyre-salte

Country Status (19)

Country	Link
US (1)	US5817659A (fr)
EP (1)	EP0773221B1 (fr)
JP (1)	JP3382103B2 (fr)
KR (2)	KR100296162B1 (fr)
CN (1)	CN1067392C (fr)
AT (1)	ATE191482T1 (fr)
AU (1)	AU707443B2 (fr)
CA (1)	CA2187409C (fr)
CH (1)	CH689831A5 (fr)
DE (1)	DE59604878D1 (fr)
DK (1)	DK0773221T3 (fr)
ES (1)	ES2145360T3 (fr)
GR (1)	GR3033727T3 (fr)
HU (1)	HUP9603072A3 (fr)
NO (1)	NO964699L (fr)
PT (1)	PT773221E (fr)
RU (1)	RU2187508C2 (fr)
TW (1)	TW533214B (fr)
ZA (1)	ZA969284B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH693255A5 (de) *	1997-06-13	2003-05-15	Eprova Ag	Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
US6358953B1 (en) *	1998-10-22	2002-03-19	Phillip B. B. Moheno	Pterin antineoplastic agents
CH693905A5 (de)	1999-04-15	2004-04-15	Eprova Ag	Stabile kristalline Salze von 5-Methyltetrahydrofolsäure.
CH694251A5 (de)	1999-07-14	2004-10-15	Eprova Ag	Herstellung von Tetrahydropterin und Derivaten.
FR2816944B1 (fr) *	2000-11-17	2005-10-21	Dospharma	Nouveaux sels de lithium, les compositions pharmaceutiques a base de ces sels de lithium et leurs applications comme medicament
KR20060051135A (ko) *	2004-09-15	2006-05-19	니프로 가부시키가이샤	안정화된 주사용 수용액 제재
US7947662B2 (en)	2008-02-20	2011-05-24	Gnosis S.P.A.	Folates, compositions and uses thereof
JP5856372B2 (ja) *	2008-02-20	2016-02-09	グノーシス・エツセ・ピー・アー	葉酸塩、これらの組成物および使用
US9492421B1 (en)	2013-11-14	2016-11-15	Argent Development Group, Llc	Nutritional supplements for treatment of iron deficiency anemia
US9629846B1 (en)	2013-11-14	2017-04-25	Argent Development Group, Llc	Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women
WO2016185413A1 (fr)	2015-05-20	2016-11-24	Nestec S.A.	Formulations à libération modifiée
RU2019134064A (ru)	2017-03-31	2021-04-30	Мерк Патент Гмбх	Кристаллическая натриевая соль 5-метил-(6s)-тетрагидрофолиевой кислоты
US11185545B2 (en)	2017-03-31	2021-11-30	Merck Patent Gmbh	Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid
EP3461826A1 (fr)	2017-09-29	2019-04-03	Aprofol AG	Sels de folate multifonctionnel
CN108976232A (zh) *	2018-09-19	2018-12-11	江苏红豆杉药业有限公司	一种四氢叶酸钙的合成方法
EP3646873A1 (fr)	2018-10-31	2020-05-06	Aprofol AG	Sels de folate
CN109456330B (zh) *	2018-11-26	2021-05-14	连云港德洋化工有限公司	叶酸类稳定复合物及其制备方法
EP4501315A1 (fr)	2023-08-04	2025-02-05	Lesaffre et Compagnie	Formulations liquides de folates
IT202300027360A1 (it)	2023-12-20	2025-06-20	Lesaffre & Cie	Formulazioni solide di folati

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5124452A (en) *	1978-07-10	1992-06-23	Bioresearch S.P.A.	Process for producing d,1-5-methyltetrahydrofolic acid and its salts
DD274631A5 (de) *	1987-09-18	1989-12-27	Kk	Verfahren zur biologischen herstellung von amiden
DE3821875C1 (fr) *	1988-06-29	1990-02-15	Eprova Ag, Forschungsinstitut, Schaffhausen, Ch
CH681303A5 (fr) *	1991-01-16	1993-02-26	Eprova Ag
CH684270A5 (de) *	1991-10-04	1994-08-15	Sapec Fine Chemicals	Verfahren zur Herstellung von Erdalkalimetallsalzen von (6R)-N(10)-Formyl-5,6,7,8-tetrahydrofolsäure.
CH686672A5 (de) *	1992-12-01	1996-05-31	Cerbios Pharma Sa	Verfahren zur Herstellung von (6S)-5,6,7,8-Tetrahydrofolsaeure.
GEP20012441B (en) *	1993-04-02	2001-05-25	Lonza Ag	Process for Preparing 3-Methylpiperidine and 3-Methylpyridine
CH686369A5 (de) *	1994-05-09	1996-03-15	Eprova Ag	Stabile kristalline (6S)- und (6R)-Tetrahydrofolseure.
CZ338596A3 (en) *	1994-05-23	1997-07-16	Lonza Ag	Catalytic mixture for oxidative amonolysis of alkyl pyridines, process of its preparation and use

1995
- 1995-11-07 CH CH03145/95A patent/CH689831A5/de not_active IP Right Cessation
1996
- 1996-10-07 TW TW085112241A patent/TW533214B/zh not_active IP Right Cessation
- 1996-10-08 CA CA002187409A patent/CA2187409C/fr not_active Expired - Lifetime
- 1996-10-14 DE DE59604878T patent/DE59604878D1/de not_active Expired - Lifetime
- 1996-10-14 PT PT96116403T patent/PT773221E/pt unknown
- 1996-10-14 ES ES96116403T patent/ES2145360T3/es not_active Expired - Lifetime
- 1996-10-14 EP EP96116403A patent/EP0773221B1/fr not_active Expired - Lifetime
- 1996-10-14 DK DK96116403T patent/DK0773221T3/da active
- 1996-10-14 AT AT96116403T patent/ATE191482T1/de not_active IP Right Cessation
- 1996-10-30 KR KR1019960050318A patent/KR100296162B1/ko not_active Expired - Fee Related
- 1996-10-31 AU AU70533/96A patent/AU707443B2/en not_active Ceased
- 1996-11-05 ZA ZA969284A patent/ZA969284B/xx unknown
- 1996-11-05 CN CN96112040A patent/CN1067392C/zh not_active Expired - Fee Related
- 1996-11-06 JP JP29416096A patent/JP3382103B2/ja not_active Expired - Fee Related
- 1996-11-06 RU RU96121625/04A patent/RU2187508C2/ru active
- 1996-11-06 KR KR1019960052354A patent/KR100702201B1/ko not_active Expired - Fee Related
- 1996-11-06 NO NO964699A patent/NO964699L/no not_active Application Discontinuation
- 1996-11-06 HU HU9603072A patent/HUP9603072A3/hu unknown
- 1996-11-07 US US08/744,952 patent/US5817659A/en not_active Expired - Lifetime
2000
- 2000-06-20 GR GR20000401421T patent/GR3033727T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
TW533214B (en)	2003-05-21
US5817659A (en)	1998-10-06
ZA969284B (en)	1997-05-07
EP0773221B1 (fr)	2000-04-05
NO964699D0 (no)	1996-11-06
HUP9603072A3 (en)	1998-01-28
KR100702201B1 (ko)	2007-11-12
KR970027048A (ko)	1997-06-24
GR3033727T3 (en)	2000-10-31
DE59604878D1 (de)	2000-05-11
AU7053396A (en)	1997-05-15
JP3382103B2 (ja)	2003-03-04
AU707443B2 (en)	1999-07-08
NO964699L (no)	1997-05-09
ES2145360T3 (es)	2000-07-01
KR100296162B1 (ko)	2001-09-10
HUP9603072A2 (en)	1997-08-28
EP0773221A1 (fr)	1997-05-14
KR970027056A (ko)	1997-06-24
CA2187409A1 (fr)	1997-05-08
JPH09169759A (ja)	1997-06-30
PT773221E (pt)	2000-09-29
RU2187508C2 (ru)	2002-08-20
ATE191482T1 (de)	2000-04-15
CH689831A5 (de)	1999-12-15
CN1067392C (zh)	2001-06-20
CA2187409C (fr)	2000-08-22
HU9603072D0 (en)	1996-12-30
CN1153176A (zh)	1997-07-02

Publication	Publication Date	Title
DE59604878D1 (de)	2000-05-11	Stabile kristalline Tetrahydrofolsäure-Salze
GB9309324D0 (en)	1993-06-16	Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives
RU96121625A (ru)	1999-01-27	Стабильная кристаллическая соль тетрагидрофолиевой кислоты
NO20001886L (no)	2000-10-16	Stabile, krystallinske salter av 5-metyltetrahydrofolsyre og fremgangsmÕte til fremstilling derav
NO962321D0 (no)	1996-06-05	Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt
AU7886087A (en)	1988-03-31	Imide derivatives ,and their production and use
FI860010A0 (fi)	1986-01-02	Basiska produkter av kinolonkarboxylsyror.
KR840007878A (ko)	1984-12-11	벤조퀴놀리진 카르복실산 유도체의 제조방법
ATE92489T1 (de)	1993-08-15	Imid-derivate, ihre herstellung und verwendung.
FI881040A0 (fi)	1988-03-07	Foerfarande foer framstaellning av kristallisk cefadroxil-monohydrat.
ATE79624T1 (de)	1992-09-15	3h-1,2,3-triazolo(4,5-d>pyrimidine.
NO933367L (no)	1990-11-16	Sterkt vannloeselige, stablie, krystallinske salter av 2',3'-dideoksyinosin, 2',3'-dideoksy-2',3'didehydrotymidin og2',3'dideoksy-2'-fluorisin, og fremgangsmaate til fremstilling derav
LV11322A (lv)	1996-06-20	Antimikrobiala savienojuma kristali
CA2016765A1 (fr)	1990-11-15	Sels cristallins stables de monohydrate de 2',3'-didesoxyinosine, de monohydrate de 2',3'-didesoxy-2',3'-didehydrothymidine, et de hemihydrate de 2',3'-didesoxy-2'-fluoroinosine, hautement solubles dans l'eau et antiviraux
ATE156824T1 (de)	1997-08-15	Verfahren zur herstellung von pyrido(1,2- a>pyrimidinderivaten
KR830009115A (ko)	1983-12-17	세파드록신 모노하이드레이트의 제조방법
HUT57779A (en)	1991-12-30	Process for producing new thiazetoquinoline-3-carboxylic acid derivatives
KR870004666A (ko)	1987-06-01	글루타민산 칼륨염의 제조방법
KR890009405A (ko)	1989-08-01	비경구용 세파만돌나페이트 제제의 제조방법